Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Mytien Goldberg

Surgery of the Hand Torrance, CA Medical Doctor

NPI 1376707711 CMS profile 244291

2808 Columbia St, Torrance, CA 90503

Open in the dashboard

General payments

$8,492

152 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Mytien Goldberg of Torrance, CA is reported in the CMS Open Payments database as having received $8,492 across 152 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 81st percentile of Surgery of the Hand profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $432 9
2024 General $594 13
2023 General $737 10
2022 General $1,304 22
2021 General $1,359 25
2020 General $1,126 25
2019 General $2,940 48

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Mytien Goldberg
  • Surgery of the Hand median
  • Middle half of Surgery of the Hand
  • National median

In program year 2025, general payments to Mytien Goldberg were reported at $432. Among 212 Surgery of the Hand profiles paid that year, the median was $312 and the middle half received between $111 and $999.

Show as a table
Year Mytien Goldberg Surgery of the Hand median Middle half National median
2019 $2,940 $337 $119–$1,310 $163
2020 $1,126 $149 $52–$588 $114
2021 $1,359 $251 $78–$776 $132
2022 $1,304 $260 $116–$1,251 $149
2023 $737 $288 $113–$961 $160
2024 $594 $372 $125–$888 $164
2025 $432 $312 $111–$999 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Sientra, Inc. $1,136 19 payments
  2. KCI USA, Inc $1,083 6 payments
  3. AxoGen $978 14 payments
  4. Musculoskeletal Transplant Foundation Inc. $866 13 payments
  5. Allergan Inc. $799 20 payments
  6. Mentor Worldwide LLC $631 18 payments
  7. Bard Peripheral Vascular, Inc. $520 5 payments
  8. Tepha Inc $446 5 payments
  9. Aroa Biosurgery Incorporated $346 5 payments
  10. Integra LifeSciences Corporation $293 15 payments
  11. Other $1,395 32 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $7,116 150 payments
  2. Consulting Fee $800 1 payment
  3. Travel and Lodging $576 1 payment
Products named General payments · program years 2019–2025
  1. SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT $1,136 19 payments
  2. VAC VERAFLO $1,013 3 payments
  3. Avance Nerve Graft $921 11 payments
  4. NATRELLE $593 15 payments
  5. GalaFLEX $446 5 payments
  6. ARTOURA Breast Tissue Expander $324 9 payments
  7. MENTOR MemoryGel Resterilizable Gel Sizer $307 9 payments
  8. MemoryShape Breast Implants $300 7 payments
  9. NOVOSORB BTM $222 2 payments
  10. Restrata Wound Matrix $209 3 payments
  11. Other $3,637 133 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

152 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Surgery of the Hand in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record